MEDTRONIC

Now Offering Both 1.5 and 3 Tesla Indications for MR-Conditional ICMs, Pacemakers, ICDs and CRT-Ds DUBLIN - February 22, 2016 - Medtronic plc...

Amplia MRI(TM) and Compia MRI(TM) CRT-Ds, Approved for Patients with Heart Failure, Can Safely Undergo Full Body MRI Scans DUBLIN - Feb. 5, 2016...

DUBLIN - February 22, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved an expanded...

Medtronic Arctic Front® Cryoballoon Catheters Meet Non-Inferiority Goal in Head-to-Head Trial Presented at ACC Scientific Sessions and...

SEER Pooled, Patient-Level Analysis of SWIFT PRIME, EXTEND-IA, ESCAPE and REVASCAT Shows Safety and Efficacy of Solitaire Device DUBLIN -...

Encouraging Early Outcomes from Rigorously Designed Study Set the Stage for IDE DUBLIN and CHICAGO - April 4, 2016 - Medtronic plc (NYSE: MDT)...

New Sub-study at ACC.16 from the CoreValve U.S. High Risk Trial Shows Exceptional Valve Performance for the Self-Expanding Transcatheter Heart...

Medtronic Receives Expanded Indication From FDA for Pillcam(TM) Colon 2 Capsule DUBLIN - March 31, 2016 - Medtronic plc (NYSE: MDT) today...

FDA Approves Medtronic Deep Brain Stimulation for People with Parkinson's Disease with Recent Onset of Motor Complications DUBLIN - February 17,...

NEWS RELEASE Contacts: Joey Lomicky Ryan Weispfenning Public Relations Investor Relations +1-763-526-2494 +1-763-505-4626 New Data at ACC.16...